Yale Autoimmune and Cholestatic Liver Disease Program
The Yale Autoimmune and Cholestatic Liver Disease Program consists of dedicated experts and support staff committed to cutting-edge care and innovative research to patients with disorders including Autoimmune Hepatitis, Primary Sclerosing Cholangitis (PSC), Primary Biliary Cholangitis (PBC). Dr. James Boyer and Dr. David Assis lead clinics specifically centered on these rare diseases and coordinate multi-disciplinary care throughout Yale. They are also active members of the Yale Liver Center, a world-class NIH-funded research center, and actively conduct a number of novel clinical and basic science research studies in this field. Further, the Yale program is a key organizer of the North American Consortium for Autoimmune Liver Disease.
Examples of recent clinical projects include a pilot study of a new drug for the treatment of PSC and a study evaluating the relationship between psychological stress and inflammation in Autoimmune Hepatitis.
For more information about the Yale Autoimmune and Cholestatic Liver Disease Program, please call 203-785-5279 or email Diane Giordano